Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  GlaxoSmithKline plc    GS7   GB0009252882

Real-time Quote. Real-time Tradegate - 07/28 10:03:33 pm
20.327 EUR   -0.84%
09:08p GLAXOSMITHKLINE : Pharma giant GSK in 110 million Montrose investmen..
02:40pDJANDREW WITTY : Brexit Could Reduce Parallel Trade in EU But Too Soon..
09:28a GLAXOSMITHKLINE : *lbbw raises glaxosmithkline price target to 1800 ..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo GlaxoSmithKline plc
Develops, manufactures and distributes vaccines and other pharmaceutical products

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.

It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.

The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.

The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.

The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
Managers
NameAgeSinceTitle
Andrew Witty512008Chief Executive Officer & Executive Director
Philip Hampton522015Non-Executive Chairman
Simon Dingemans522011Chief Financial Officer & Executive Director
Moncef Slaoui, PhD552006Executive Director & Chairman-Global Vaccines
Roy Malcolm Anderson682007Independent Non-Executive Director
Stacey Cartwright522011Independent Non-Executive Director
Judy Carol Lewent672011Independent Non-Executive Director
Lynn Laverty Elsenhans, MBA592012Independent Non-Executive Director
Urs Rohner572015Independent Non-Executive Director
Manvinder Singh Banga612015Senior Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 5,363,871,303 4,830,481,880 90.1% 491,515,950 9.2% 90.1%
Shareholders
NameEquities%
BlackRock Investment Management (UK) Ltd. 199,772,316 4.10%
Legal & General Investment Management Ltd. 149,809,659 3.08%
The Vanguard Group, Inc. 116,803,851 2.40%
Capital Research & Management Co. (Global Investors) 102,630,000 2.11%
Norges Bank Investment Management 92,641,000 1.90%
State Street Global Advisors Ltd. 61,837,101 1.27%
Aberdeen Asset Investments Ltd. 60,048,162 1.23%
Threadneedle Asset Management Ltd. 59,691,735 1.23%
GlaxoSmithKline Employee Trust 52,734,605 1.08%
Woodford Investment Management LLP 52,369,825 1.08%
Holdings
NameEquities%Valuation
Aspen Pharmacare Holdings Limited (APNJ) 28,234,3796.19%698,446,539 USD
Innoviva Inc (THRX) 32,005,26028.3%337,015,388 USD
Theravance Biopharma Inc (TBPH) 9,644,80720.3%218,840,671 USD
GlaxoSmithKline S.A.E. 76,161,37891.2%73,760,010 USD
Dong-A Socio Holdings Co Ltd (000640) 409,6938.46%62,422,296 USD
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSM) 555,081,92646.4%45,194,770 USD
Oncomed Pharmaceuticals Inc (OMED) 2,607,5468.61%32,098,891 USD
Allergy Therapeutics plc (AGY) 10,118,0001.72%2,502,283 USD
NeuroSearch A/S (NEUR) 1,950,5007.94%728,141 USD
Response Genetics, Inc. (RGDXQ) 5,000,00012.9%5,000 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC6.58%108 962
JOHNSON & JOHNSON21.47%343 198
PFIZER INC.14.16%223 490
ROCHE HOLDING LTD.-9.99%216 972
NOVARTIS AG-5.30%216 918
MERCK & CO., INC.10.94%162 206
BRISTOL-MYERS SQUIBB C..11.16%127 652
NOVO NORDISK A/S-4.68%113 127
SANOFI-2.42%109 416
GLAXOSMITHKLINE PLC23.56%108 962
ALLERGAN PLC-16.72%102 940
ELI LILLY AND CO-1.02%92 115
BAYER AG-19.20%86 601
ASTRAZENECA PLC1.59%77 857
ABBOTT LABORATORIES-2.76%64 158
SHIRE PLC4.45%57 889
TEVA PHARMACEUTICAL IN..-17.60%49 808
ASTELLAS PHARMA INC-1.34%34 951
TAKEDA PHARMACEUTICAL ..-24.45%34 281
MYLAN NV-13.21%23 858
CHUGAI PHARMACEUTICAL ..-7.31%20 977
Sector Pharmaceuticals - NEC
GlaxoSmithKline plc : Connections
Alfred Escher-Stiftung
The Council for Industry & Higher Education
United Kingdom Department for Business, Innovation & Skills
Mauser Group NV
The 100 Group
National Theatre of Scotland
The Institute of International Finance, Inc.
Biotechnology Innovation Organization
International Institute for Management Development
International AIDS Vaccine Initiative, Inc.
Diversey, Inc.
Longwood Fund Management LLC
United Way of Greater Philadelphia & Southern New Jersey
The Natural History Museum
Credit Suisse Americas Foundation
Institute of Medicine
Opernhaus Zürich AG
French Academy of Sciences
Economiesuisse
Imperial College London
Swiss Finance Council
Pearson Education Ltd.
Diversey Holdings, Inc.
Harvey Nichols Group Ltd.
World Presidents' Organization
Burberry Spain SA
Central Houston, Inc.
Business Council for Britain
The First Tee of Greater Houston
Singapore Economic Development Board
Credit Suisse AG
Rockefeller Family Trust, Inc.
Zurich Chamber of Commerce
American Academy of Arts & Sciences
Institute International d'Etudes Bancaires
Massachusetts Institute of Technology
Lucerne Festival
Sunoco Chemicals, Inc.
Avenir Suisse
Sunoco Partners LLC
IMD Scholarship Foundation
The University of Nottingham
Swiss Bankers Association
Indian School of Business
European Financial Services Round Table
Pharmaceutical Research & Manufacturers of America
European Federation of Pharmaceutical Industries & Assns
Rice University
GlaxoSmithKline, Inc.
World Golf Foundation, Inc.
Indian Institute of Management
The Texas Medical Center
The Indus Entrepreneurs (Delhi)
United Way of Greater Houston
Clayton Dubilier & Rice LLP
Company contact information
980 Great West road
TW8 9GS Brentford, Greater London
United Kingdom

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  GB0009252882
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem